Predict your next investment

Corporation
precisionhh.com

See what CB Insights has to offer

About Precision Health Holdings

Precision Health is a specialized medical research company dedicated to supporting the development and commercialization of personalized medicines and therapies.

Precision Health Holdings Headquarter Location

4445 Willard Avenue Suite 710

Chevy Chase, Maryland, 20815,

United States

240-654-0730

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Precision Health Holdings News

PE HUB » SeraCare Life Sciences Divests Biorepository Business

Jan 7, 2013

Friends (332) January 7, 2013    1 Views    0 Comments SeraCare Life Sciences, a portfolio company of Linden Capital Partners, has sold its biorepository, biobanking and laboratory services business to Precision Health Holdings. The Maryland-based business includes biorepository and biobanking services and certain laboratory services. PRESS RELEASE SeraCare Life Sciences, a portfolio company of Linden Capital Partners serving the in vitro diagnostics and clinical laboratory markets, today announced that it has sold its biorepository, biobanking and laboratory services business to Precision Health Holdings, Inc. This Maryland-based business includes biorepository and biobanking services, AccuCell® products and certain laboratory services. “The sale of our Biorepository business is an important element in our growth strategy for SeraCare,” said Charles Mamrak, CEO of SeraCare. “We can now more freely serve our growing customer base in the in vitro diagnostics market and execute on our mission of improving quality of life by advancing a global understanding of disease.” The transaction includes the transfer of Biorepository assets and employees. Financial terms of the transaction were not disclosed. SeraCare Life Sciences was advised by BroadOak Partners LLC and Kirkland & Ellis LLP during the transaction. About SeraCare Life Sciences, Inc. SeraCare partners with diagnostics researchers, IVD manufacturers and clinical laboratories to shape the future of medical diagnostics. Our innovative portfolio includes ACCURUN® quality controls, research panels, SeraCon® processed biological materials, specialty human blood products and characterized disease state materials. SeraCare helps bridge the gap between today’s diagnostic solutions and tomorrow’s emerging technologies for molecular diagnostics, next generation sequencing and companion diagnostics. For more information, visit www.seracare.com. About Linden Capital Partners Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden currently has investments in middle market platforms in the products, distribution, and services segments of healthcare. Leave a Reply

Precision Health Holdings Acquisitions

1 Acquisition

Precision Health Holdings acquired 1 company. Their latest acquisition was SeraCare Life Sciences - Biorepository Business on January 07, 2013.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/7/2013

Acquired Unit

1

Date

1/7/2013

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired Unit

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.